Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
about
Neoadjuvant chemotherapy in oral cancers: Selecting the right patientsProteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of NoxaIdentification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavityChemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expressionCCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature.Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TILow Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation gradeLong-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma.Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal.Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.Clinicopathological evaluation of pre-operative chemoradiotherapy with S-1 as a treatment for locally advanced oral squamous cell carcinoma.Management of gingivobuccal complex cancer.A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck.Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults.Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis.Histopathological assessment of tumour regression, nodal stage and status of resection margins determines prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy.Outcome of Neoadjuvant Chemotherapy on Local Recurrence and Distant Metastasis of Oral Squamous Cell Carcinoma: A Retrospective Study.Kikuchi-Fujimoto disease in the regional lymph nodes with node metastasis in a patient with tongue cancer: A case report and literature review.Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone.Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.Impact of metronomic neoadjuvant chemotherapy on early tongue cancer.Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.Evaluation of neo-adjuvant, concurrent and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma: a meta-analysis.Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?Concurrent preoperative chemotherapy and three-dimensional conformal radiotherapy followed by surgery for oral squamous cell carcinoma: a retrospective analysis of 104 cases.Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.The changing role of surgery in the current era of head and neck oncology.Concurrent chemoradiotherapy with pirarubicin and 5-fluorouracil for resectable oral and maxillary carcinoma.Induction Chemotherapy in Technically Unresectable Locally Advanced T4a Oral Cavity Squamous Cell Cancers: Experience from a Regional Cancer Center of South India.Prognostic importance of pathological response to neoadjuvant chemotherapy followed by definitive surgery in advanced oral squamous cell carcinoma.Evolution of oral neoplasm in an andalusian population (Spain).Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma.Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.
P2860
Q26768434-6D25DC9B-88E9-43B9-B7F6-2018EFA4FA6EQ28259620-C97B84DD-1EF6-42D9-978C-3898D0DE4410Q28273903-E13E2345-B042-47A8-8242-10C6955A34A8Q28535295-25616C51-9F27-4149-A392-65F7CE798166Q31040425-006195CE-A594-47D4-B067-1A2F100CF8F3Q34407889-87D892F1-4D58-4FD0-A401-E7D7C1D8E15EQ34452702-E9293C66-66E3-4807-8D48-C56B9BA702F3Q34779430-56C7867B-F5B5-4F7A-B78B-BCAC180F8068Q36210999-B827ABEC-6268-4810-B3B4-D9159A17882CQ36549733-247F24EC-4B0A-4E99-8311-11A7ADDF42B1Q36697794-59FB9659-8869-44AA-A720-4EBAFAB201A7Q36825880-157B6F48-C8B0-4BF4-B706-9DE3921B5F5BQ37242963-9CFB0870-D4B0-4F22-BB81-358C2CBD8DA5Q37322374-5EE6A28B-E207-4DA8-89D8-3139D8D07690Q37336466-DC54397C-6AF7-42D5-BD44-1A462FC17AC9Q37364496-5158EF3E-65C3-4678-830F-FBDB3E24E85AQ37483635-383156BD-63DE-4FA1-B23A-4EBC733AAFD0Q37594771-FC6FEF56-4E7A-41D7-9378-745760388426Q37658802-25CB4DBE-21A0-4A90-B028-80DE20977FA6Q37799933-FA4BD40E-AE45-4B8D-822B-712616BA4DBBQ37930854-7FA14E39-111C-4EE7-931B-E79EB1364721Q39405849-B2A1F60B-8023-4869-AD49-EE053A4A08C0Q39415046-646DCCDF-21E4-499B-A2EB-E2490EC8918FQ39425980-44EE3BFE-D7BA-4BF0-8687-9AB80E698EA8Q40060938-845662A0-64DE-4C52-917A-7CED558DD8B1Q40121235-EFB61B68-4FFC-4D80-B076-CBE325E093ECQ40601341-4710C875-2B98-4521-90D7-852AAFD39628Q41508310-8A3201C5-86CE-4FB5-BC33-17F900225A59Q41515794-47F4D9C8-2547-477A-94A8-A369B0805F23Q42963762-0D8E6903-D02E-4A70-AAD9-F7A65FF1DE55Q43182841-F20C30EA-977B-4EE6-92EF-E3C416B73F3DQ43234029-49C8A0A7-A7C0-443D-B6B9-AEBAE7233CAEQ43833419-35BC5F32-DD47-401B-8416-E20CD702727CQ43977483-CB545D2C-EF83-4077-A609-77A8CEA11495Q45129609-290374C9-F2D0-4AC8-8B23-381359D90ECBQ49401203-751BD3D0-EC90-4259-A54E-CAB6A32D0360Q49556301-4235A563-F916-4626-B619-C98B99C41BB5Q49603310-8C8551A3-9E3F-4893-BBFA-4AB6A18CAD72Q49638561-71C81707-091F-41A7-AC0A-893467E5A4C6Q51440935-E247B99C-4AFF-4F2F-909C-EF3CCB121C48
P2860
Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Primary chemotherapy in resect ...... a randomized controlled trial.
@en
Primary chemotherapy in resect ...... a randomized controlled trial.
@nl
type
label
Primary chemotherapy in resect ...... a randomized controlled trial.
@en
Primary chemotherapy in resect ...... a randomized controlled trial.
@nl
prefLabel
Primary chemotherapy in resect ...... a randomized controlled trial.
@en
Primary chemotherapy in resect ...... a randomized controlled trial.
@nl
P2093
P50
P356
P1476
Primary chemotherapy in resect ...... a randomized controlled trial
@en
P2093
Cesare Grandi
Francesca Valvo
Gianni Bonadonna
Giulio Cantù
Pinuccia Valagussa
Roberto Molinari
P304
P356
10.1200/JCO.2003.06.146
P407
P577
2003-01-01T00:00:00Z